Multi-Site Trial of Combined Pharmacotherapy to Treat Cocaine Dependence
A study of two medications together to treat cocaine dependence
Sponsor: National Institute on Drug Abuse
Enrolling: Male and Female Patients
Study Length: 14 Weeks
Clinic Visits: 42
IRB Number: 6698
U.S. Govt. ID: NCT01811940
Contact: Daniel Brooks: 212-923-3031 / brooksd@nyspi.columbia.edu
Additional Study Information: The study is a two group outpatient study, one group receiving medications (Adderall-XR and topiramate) and one group receiving a placebo (inactive sugar pill). The study is looking at the safety and effectiveness of Adderall-XR (MAS-ER) and topiramate in the treatment of cocaine dependence. It is a 14-week trial that requires patients to attend visits 3 times per week.
This study is closed
Investigator
Frances Levin, MD
Do You Qualify?
Are you currently using cocaine? Yes No
Do you use cocaine at least weekly? Yes No
Are you between the ages of 18 and 60? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder



Cancel
For more information, please contact:
Daniel Brooks
brooksd@nyspi.columbia.edu
212-923-3031
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE